Qualigen Therapeutics
QLGN
QLGN
18 hedge funds and large institutions have $67.2K invested in Qualigen Therapeutics in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
39% less capital invested
Capital invested by funds: $110K → $67.2K (-$42.4K)
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$12K | |
| 2 | +$7.97K | |
| 3 | +$3.83K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$3.12K |
| 5 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
+$2.76K |
Top Sellers
| 1 | -$22.3K | |
| 2 | -$2.02K | |
| 3 | -$1.11K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$16 |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$9 |